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Synthesizing evidence from quasi-experimental studies presents surmountable challenges 
 
 
ABSTRACT 
 
 
Objective: To outline issues of importance to analytic approaches to the synthesis of quasi-
experiments (QEs), and to provide a statistical model for use in analysis. 
 
Study Design and Setting: We drew on the literatures of statistics, epidemiology, and social-
science methodology to outline methods for synthesis of QE studies. The design and conduct of 
quasi-experiments, effect sizes from QEs, and moderator variables for the analysis of those effect 
sizes were discussed. 
 
Results: Biases, confounding, design complexities and comparisons across designs offer serious 
challenges to syntheses of QEs. Key components of meta-analyses of QEs were identified, 
including the aspects of QE study design to be coded and analyzed. Of utmost importance are the 
design and statistical controls implemented in the QEs. Such controls and any potential sources 
of bias and confounding must be modeled in analyses, along with aspects of the interventions 
and populations studied. Because of such controls, effect sizes from QEs are more complex than 
those from randomized experiments. A statistical meta-regression model that incorporates 
important features of the QEs under review was presented. 
 
Conclusion: Meta-analyses of quasi-experiments provide particular challenges, but thorough 
coding of intervention characteristics and study methods, along with careful analysis, should 
allow for sound inferences. 
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WHAT-IS-NEW BOX 
 
 
Synthesizing evidence from quasi-experimental studies 
  
  
Meta-analyses of quasi-experiments must investigate moderators that capture key 
features of the interventions examined and methods used in the primary studies.  
 
The use of statistical and design controls in quasi-experiments leads to complexities in 
representing QE study effects, as well as in analysis of those effects. 
 
Exploring potential sources of bias and confounding is especially critical when modeling 
effects from quasi-experimental designs. The use of meta-regression models facilitates 
such analyses. 
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1  INTRODUCTION 
 Syntheses that include quasi-experiments must consider a variety of design and analysis 
issues that greatly increase the complexity of the meta-analysis process. The growing importance 
of synthesizing quasi-experiments is evidenced by a recent special issue of Research Synthesis 
Methods (Volume 4, Issue 1), though research on this topic dates back 30 years (Bryant & 
Wortman, 1984; Wortman, 1992). In this work we discuss key elements of potential analytic 
approaches to the synthesis of quasi-experiments, and provide a broad statistical model for use in 
analysis. 
 Other papers in this themed issue of the Journal of Clinical Epidemiology describe how 
quasi-experimental studies can be identified for evidence synthesis (Glanville et al. 2017), how 
data is best collected from quasi-experimental studies (Aloe et al. 2017), and how the global 
capacity for including quasi-experimental studies in evidence synthesis can best be expanded 
(Lavis et al. 2017, Rockers et al. 2017). In this paper, we begin with a brief discussion of several 
definitions of quasi-experiments (QEs) and describing some challenges that arise in synthesizing 
QEs.  We next describe the information required to carry out such a synthesis. This includes 
information on effect sizes, study features, and the details of the models examined in the primary 
QE research. We conclude with potential unresolved issues in this domain. 
 
2  QUASI-EXPERIMENTAL DESIGNS 
 Campbell and Stanley (1966) introduced the term “quasi-experiment” in their seminal 
book on design of studies. They described QEs as “settings in which the research person can 
introduce something like experimental design… even though he lacks the full control over the 
scheduling of experimental stimuli… which makes a true experiment possible” (p. 34). They 
outlined ten different QE designs. Rockers et al. (2015) drew on this definition and several others 
to arrive at a different definition, writing that QEs “… estimate causal effect sizes using 
exogenous variation in the exposure of interest, which is not directly controlled by the 
researcher” (p. 511). They continue “… five commonly used designs … fit our definition of 
quasi-experiments: natural experiments, instrumental variable analyses, regression discontinuity 
analyses, interrupted times series studies, and difference studies including controlled before-and-
after designs, difference-in-difference designs and fixed effects analyses of panel data” (p. 511). 
Rockers et al. distinguish between study designs that control all confounding (observed and 
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unobserved), observed and some unobserved confounding, or only observed confounding. These 
distinctions emphasize the important role of confounding in the synthesis of QEs. Bärnighausen 
et al. (2017) describe the assumptions that need to be met in different types of quasi-
experimental studies that replace the (strong) unconfoundedness assumption in non-experimental 
studies.    
 
 Various other terms are used across different disciplines to refer to the diverse array of 
nonrandomised studies (e.g., observational studies, natural experiments, cohort designs) not all 
of which are considered QEs. For example, the Cochrane Collaboration Handbook (section 
13.2.2 at 
http://handbook.cochrane.org/chapter_13/13_2_2_guidance_and_resources_available_to_support
_review.htm) tables the features present in 18 non-randomized study designs, and urges 
reviewers to use those design features to determine which studies might be included in a review. 
Also Wells et al. (2013) provide a checklist of design features that may help classify a study 
design. For the meta-analyst, relying on the features of studies may be more informative than 
deciding on inclusion based on global labels (with no discussion of details of design). 
 These lists, along with Campbell and Stanley’s ten original designs from 1966, make 
clear that QEs are complex, are not themselves internally coherent, and are labelled in diverse 
ways across fields, which leads to some of the myriad challenges encountered in syntheses of 
QEs. These issues are compounded in reviews that combine QEs with other kinds of study 
designs, most critically with experiments.   
 A fundamental feature of experiments is that units of interest are assigned to treatment 
conditions randomly and independently (or randomly with explicit constraints, as in randomized 
blocks designs). In QEs, the treatment or exposure is not so tightly controlled, and randomization 
is not, or cannot be, fully achieved.  Because treatments are not randomly assigned to units (or 
vice versa), QEs usually involve designs and analyses that attempt to control confounders and 
other biases in other ways.  However, the fact that an analysis includes control variables does not 
make it a QE. Rockers et al. (2015) and Bärnighausen et al. (2017) further elaborate on 
confounding control in quasi-experimental studies.  
 Wells et al. (2013) provide a checklist of other issues for reviewers to consider when 
attempting a review that may include QEs (or other nonrandomized studies, in their 
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nomenclature). They describe protocol development for the review, primary-study assessment, 
and outcome assessment (within study). We draw on their checklist because it is quite thorough, 
but we do not deal with protocol development in our discussions, because in syntheses we deal 
only with completed studies. (Reeves et al. (2017) provide an update and extension of this 
checklist in this issue.) 
 QEs can vary widely in terms of how control is exercised, and how potential confounding 
is handled. This diversity leads to design-based and/or analysis-based variation in study 
outcomes. This occurs both across designs (e.g., comparing natural experiments versus time-
series designs) and within any given type of design. Design decisions such as selecting restricted 
samples may be made to “control” variance that in other studies is dealt with statistically (e.g., 
with covariates or stratification). For example, age is often a relevant control variable in health 
studies. However, some studies may control for age by restricting the sample to a particular age 
group while other studies include a wider variety of participant ages and use age as a covariate in 
the analytic model. Thus control variables may be part of the analysis in some QEs, whereas they 
will not in others. In both cases, control is exerted. Other design and analysis approaches may be 
used to deal with potential confounding and other biases. Wells et al. (2013) give extensive 
suggestions on how to evaluate whether primary studies have dealt with confounding. Extracting 
(Aloe et al., this issue) and analyzing information on biases and controls is critical in a synthesis 
of QEs. Understanding the relevant counterfactuals for included designs may be helpful in 
choosing what features to extract. 
 In addition, design features and other study characteristics such as the nature of the 
population or features of the interventions or outcome measure used may be confounded across 
studies in any review of research, leading to entangled conclusions about effects (Lipsey, 2003).  
This will likely be an issue when different types of QEs are summarized, especially if quasi-
experiments and true experiments are synthesized together. As one example, Kownacki and 
Shadish (1999) summarized studies of a variety of Alcoholics Anonymous (AA) rehabilitation 
programs. They discovered that randomized controlled trials (RCTs), in the main, had examined 
populations of persons mandated to attend AA because of drunk driving or other offenses. These 
randomized studies showed poorer results for AA than did nonrandomized studies. In contrast, 
the nonrandomized designs (some of which appeared badly biased) examined other types of 
attendees.  
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 Kownacki and Shadish found that study design and subpopulations studied were greatly 
confounded, with biases in the mix as well. The feature confounded with study design was 
subpopulation, but any study feature could be confounded with study design (e.g., QEs may aim 
at larger samples of the population than RCTs, thus treatments may be less well implemented 
because of sheer study size). If QEs and RCTs are included in one synthesis, their features must 
be coded and examined statistically. Graphical displays such as grouped forest plots will also 
prove useful. This holds as well for syntheses with different kinds of QEs in the mix (and no 
RCTs). Aloe and co-authors (this volume) discuss the coding of QE studies in detail. 
Because study features may be confounded with each other and with aspects of design in 
particular, meta-analysts should always examine the correlations among study features of 
interest. High correlations among study features mean that clear conclusions may not be 
reachable for a particular research domain (e.g., Becker, 1986, pp. 203-204). This also means 
that multiple predictor variables may provide competing explanations of the variation in study 
results. If correlated predictors appear together in a meta-regression model, the issue of 
multicollinearity may also arise. Rubin (1992) noted that all meta-analyses are at high risk of 
confounding of study features, due to the survey-like nature of the data-collection process.  
 To summarize, the large heterogeneity inherent in QEs and other study designs presents 
both challenges and opportunities to reviewers. However, as Berlin (1995) noted in an 
assessment of the potential to synthesize observational studies, “heterogeneity is our friend.” 
When diverse studies are analysed properly, heterogeneity can lead to better understandings of 
phenomena of importance. Take the AA example above: Coding and analyzing differences due to 
each study’s research design, population characteristics (including whether participation was 
mandatory), and their interactions will tease out much more useful information about the 
effectiveness of AA than any simple meta-analysis of just the subset of RCTs or QEs involved.    
 
3  WHAT IS NEEDED TO DO A META-ANALYSIS OF QES? 
3.1  Effect sizes 
 Meta-analyses require measures of effect magnitude that can be compared across studies. 
Effect sizes for QEs are discussed in detail by Aloe et al. (this issue). For each study (or sample, 
for studies with multiple samples), the meta-analyst should extract both an estimate of effect size 
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and its standard error (SE). If a study does not report standard errors they may be available from 
related test statistics (e.g., t tests, p values). Effect estimates can be obtained from observed 
significance levels, but if the SE cannot be obtained or imputed the study may need to be dealt 
with in a narrative fashion.  
 3.1.1  Partial and bivariate effects. Because QEs aim to assess the effectiveness of 
treatments, the fundamental effect of interest is likely to be based on a mean difference or 
comparison of counts or odds. However, because of the complexities of quasi-experimental 
designs, the effect size will nearly always be something other than a simple standardized mean 
difference (d, as in Hedges & Olkin, 1985), or a simple odds ratio. Aloe et al. (this issue) discuss 
the computation of effect sizes for QE studies. Thus here we only note that when varied 
analytical approaches are used in QEs, their effect sizes will likely not be estimating “the same” 
(i.e., mathematically identical) parameters across studies. Most effect sizes will likely be partial 
(adjusted) effects, arising for instance from multiple regression analyses where covariates control 
for confounds and explain variation in the outcome (e.g., Aloe & Becker, 2011; Keef & Roberts, 
2004). Their magnitudes will depend on what is included in each study’s analysis. Therefore 
during data extraction meta-analysts must code detailed information about the covariates and 
design approaches used – be they design controls, statistical control variables, other predictors of 
interest, or all of the above. 
 If some studies in a synthesis report bivariate effects and others report partial effect sizes, 
the reviewer must decide how to proceed. One option is to include all effects and ignore 
differences between them. This is potentially problematic because partial effect sizes estimate 
different parameters and can be larger, smaller, or even opposite in sign from bivariate effects 
because of the variables that were adjusted for (Aloe, 2014). We recommend that reviewers 
record whether each effect is bivariate or partial (and also extract information on use of specific 
control variables in each QE), and test for differences in effect sizes across effect-size types. 
Distinctions can also be made between QE studies that control for the effects of other variables 
by design (and may provide bivariate effect sizes) versus other QEs with partial effects that 
adjust for other variables statistically.  
 Several analytic options are possible. Most simply, the meta-analyst could report separate 
analyses for bivariate effects and partial effects. This strategy also may be valuable when QEs 
and experiments both appear in a synthesis. Alternately one could summarize all bivariate and 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
8 
 
partial effects together, using a meta-regression model to capture what is controlled in each 
study.  
 3.1.2  Effects from very different designs. Studies with quite different designs may 
need to be analyzed separately. Aloe et al. (this issue) pointed out that even within different types 
of QE designs primary studies could be estimating different types of study-level effects.  
Separating studies by design may be especially useful when design type is confounded with the 
type of effect size that is reported or with population type, as in Kownacki and Shadish (1999). 
However doing nothing more than just separating the sets of studies misses an important 
opportunity to statistically control for study-level quality differences, biases, and confounders. 
Thus the meta-analyst needs to consider whether the parameters being estimated in the array of 
studies collected in the review are commensurable “enough”, and thus could be analyzed 
together, or whether they are so fundamentally different estimators thus should be kept apart. 
 3.1.3  Multiple effects. Sometimes primary studies report several models – either 
examining distinct subsamples of participants or showing contributions of different subsets of 
predictors. If a study reports models for non-overlapping, independent subsamples, effects can be 
extracted from each without great concern for statistical dependence. 
 In contrast, when several models are estimated for the same participants it can be 
problematic to include the multiple effects that represent them if they are treated as independent 
effects. For example, a study may examine how a treatment impacts two outcomes, say blood 
pressure and quality of life. Or researchers using regression methods to estimate the impact of an 
intervention on one outcome may present findings from models where they have adjusted for 
many, few, or no covariates, and the results may differ from one model to another. Some meta-
analysts have extracted effects from all models given in each primary study, even when they are 
estimated for a single sample. This practice leads to violations of the independence assumption 
required by univariate analyses of effect sizes (Becker, Aloe, & Olkin, under review), and 
privileges results from studies that report more models by giving them more weight in the 
analysis.  
 If a study has examined how a predictor (e.g., an intervention) relates to two different 
measures of the same outcome, a variety of different approaches exist for handling the well-
understood covariation between the effect sizes for those two relationships. Reviewers can use 
either some a priori objective criterion for selecting one estimate per study (e.g., taking an 
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average of the two effects, selecting the estimate that maximizes similarity with other studies in 
the meta-analysis, randomly selecting one estimate) or employ more sophisticated analyses that 
accommodate within-study dependence.  Becker (2000) and others have discussed at length 
potential choices of a single effect.  Generalized least squares (GLS; Berkey et al., 1996; 
Raudenbush, Becker & Kalaian, 1988; among others) and computing cluster-robust standard 
errors (Hedges, Tipton, & Johnson, 2010) adjust the variance-covariance matrix for within-study 
dependence and thereby correct confidence intervals and resulting inferences.  Unbalanced 
panel, multi-level, and hierarchical linear (HLM) models have been widely used by meta-
analysts to accommodate within study dependence (Kalaian & Raudenbush, 1996; Rosenberger 
& Loomis, 2000; Stanley & Doucouliagos, 2012; Van Den Noortgate et al., 2013). Some 
approaches described in the literature are simple, but are not effective at accounting for 
dependence (e.g., including effects for all outcomes or models, and weighting them by the 
inverse of the number of reported estimates per study). 
 Criteria for selecting a single model to represent the meta-analysis parallel the 
suggestions for addressing situations in which a study presents more than one measure of the 
same outcome. For example, researchers could select one model based on objective criteria 
stated a priori, such as the model with the most predictors, the model that best approximates the 
meta-analyst’s view of the selection process, or the model that includes a specific pattern of 
covariates. Meta-analysts might also consider requesting that the primary-study authors run a 
specific model (i.e., a model with the meta-analysts’ preferred set of covariates), or could request 
the original data run the desired analysis themselves. 
3.2  Key theoretical variables 
 Perhaps obviously, the meta-analyst should extract critical population and setting 
characteristics.  Frameworks such as PICOS (Patients, Intervention, Comparisons, Outcomes, 
Study Design; Richardson et al., 1995) or MUTOS (Methods, Units, Treatments, Observations, 
Settings) can guide selection of relevant features (Cronbach, 1982; see also Becker, 1996; 
Becker & Aloe, 2008). It may be useful to define an ideal target study (Sterne et al., 2013) and 
characterize studies based on its critical features. Slavin argued that “…a useful organizing 
principle is the need to be strict on issues with potential for bias and liberal on issues that have 
little such potential” (2008, p. 7). Other between-studies differences that might affect reported 
study outcomes should also be extracted. 
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3.3  Design information 
 3.3.1  Nature of relevant comparison. Wells et al. (2013) argued that the first defining 
characteristic of a nonrandomized design study is whether two (or more) groups are compared, 
or a single group is measured over time. These design types differ both conceptually (Valentine 
& Thompson, 2013) and statistically. Conceptually, QE designs can differ in terms of the logic 
underlying the counterfactual condition (e.g., a design might estimate an average treatment 
effect, or a local average treatment effect, see e.g., Imbens & Angrist, 1994). Also a single-group 
design has no untreated comparison group, implying no placebo effect is expected. The statistical 
issue that makes multi-group versus single-group effects different is the dependence of measures 
over time. This causes effect sizes from time-series designs to be distributed differently from 
effects based on independent groups. This topic has been extensively discussed for effect sizes 
for continuous outcomes from experimental designs (e.g., Becker, 1988, Gibbons et al. 1993; 
Morris & Deshon, 2002). More recent work covers multivariate categorical outcomes (Trikalinos 
& Olkin, 2008, 2012).  
 A second facet of the nature of the comparison for each study is whether treated and 
control groups are based on individuals or clusters of individuals. Clusters of individuals in 
neighborhoods, villages or other units such as medical practices may figure in the provision of 
treatment, or may simply exist as part of the data collection approach in a primary study. The 
nesting involved in clustered study designs needs to be considered in the computation and 
analysis of effect sizes (e.g., Hedges, 2007). The choice of effect size (e.g., what variance is used 
to standardize a mean difference) will depend on the nature of the desired comparisons.  
 3.3.2  Group formation. The manner in which groups are formed can impact the 
distributions and behavior of effect sizes. Recent work on within study comparisons, a method 
for understanding the conditions under which the results of QEs can approximate the results of 
RCTs, suggests that researchers must understand, and be able to model, the group formation 
process (e.g., Cook, Shadish, & Wong, 2008). Thus we concur with Wells et al. that reviewers 
must record as much detail as possible about how groups are created – by the researcher or via 
other processes such as self-selection, location, and so forth.  
 3.3.3  General analytic approach. Because primary studies vary in the ways control is 
exerted, meta-analysts must document the analytical models used in each QE. The control 
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variables used – either as design or analysis features – should be examined in the meta-analysis. 
Lists of theoretically relevant variables or potential confounders/biases in the studies can guide 
data extraction. DuMouchel (1994) has argued for coding whether particular design features or 
control variables are missing (rather than present), and whether confounders are present. Coding 
features as missing allows the intercept in a model of effect size to represent the effect from an 
ideal study, with other coefficients representing the presence of confounders or biasing features. 
This approach is in line with Rubin’s (1992) concept of predicting out to an ideal study, rather 
than modeling only the kinds of studies that exist in the literature. Risk of bias tools (e.g., 
Higgins & Altman, 2008; Higgins et al., 2011; Waddington et al., this issue) and considerations 
of target studies (e.g., Sterne et al., 2013) may be of use in this task.    
 Some authors have used risk-of-bias instruments to create scores. Information is scant on 
the psychometric properties of these instruments (e.g., inter-item correlations, agreement among 
raters; but see Armijo-Olivo et al., 2012, 2013). The advantage of using such scores as 
moderators in meta-regression is simplicity (and spare use of data; having a single score leads to 
a one degree of freedom test). The disadvantage is that different sources of bias in a study may 
cancel out or compensate for each other; this information is lost when using one single bias 
score. Further, there is no reason to believe that a single score arising from a quality scale is 
valid. However, some assessment of study quality is critical, especially because different types of 
QEs may be differentially at risk for particular biases. For instance, lengthy interrupted time 
series designs are more susceptible to attrition than one-shot studies. Modeling each potential 
bias (e.g., with separate predictors for selection bias, attrition, incomplete reporting, etc.) allows 
for the examination of specific sources of bias.  However, it uses more degrees of freedom, 
requires more studies for modeling in a meta-regression context, and to the extent biases are 
correlated could suffer from collinearity. 
 
4  WHAT META-ANALYSES OF QES SHOULD INCLUDE 
 Given the above information, what should the meta-analyst include or report in a 
synthesis of QEs? As in any meta-analysis the effect sizes (and their variances) must be 
described. If several types of effects are synthesized together, this choice must be justified. 
Descriptions (including statistical summaries) of the coded variables and graph(s) displaying the 
effect sizes are needed.   
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 Authors must examine moderator variables in weighted regressions, analysis-of-variance-
like approaches, or Bayesian models. We recommend accommodating for heteroscedasticity via 
inverse variance weighting (e.g., weighted least squares and generalized least squares) as 
described below. In the case of within-study dependence (e.g., multiple outcomes per study) 
generalized least squares analyses (Berkey et al., 1996; Raudenbush, Becker & Kalaian, 1988; 
among others), cluster-robust standard errors (Hedges, Tipton, & Johnson, 2010), unbalanced 
panel methods (Rosenberger & Loomis, 2000; Stanley & Doucouliagos, 2012), multi-level 
models (Kalaian & Raudenbush, 1996) or data reduction may be required.  
 After this, other typical meta-analytic methods should be applied. We recommend 
robustness checks and investigations of publication and other biases. Outlier and influence 
analyses (e.g., eliminating or adjusting certain extreme estimates, or sets of effects) may be 
especially important. Higgins and Thompson’s (2004) permutation test may be useful especially 
for meta-analyses with small numbers of studies. A discussion of alternative explanations of 
results is critical because study features and predictor variables tend to be confounded in meta-
analyses.   Assessment of the generalizability of the conclusions should include a close 
evaluation of remaining threats/existing weaknesses. Collinearity among the coded features 
should be assessed (e.g., by cross-tabulating or correlating moderator variables); this may reveal 
confounding among study features in the literature, and preclude adoption of a single “best 
explanation” of variation in study effects.  Review authors may also find it useful at this point to 
assess the overall quality of the literature using a system like GRADE (Grade Working Group, 
2004; Guyatt et al., 2008) that has been adopted by the Cochrane Collaboration, among others. 
GRADE views bodies of evidence based on randomized trials to be of the highest quality, but 
says nothing about how to grade reviews that combine RCTs and QEs. Last, gaps in analyses, or 
the literature more generally, should be described, along with the inevitable questions for future 
research. 
 
5  STATISTICAL FRAMEWORK 
 As noted above a range of possible statistics can serve as effect sizes in QEs. Thus we use 
a general notation system, with details to be determined by the reviewer’s choice of metric.  
Consider k quasi-experimental studies of a particular topic of interest with comparable effect 
sizes T1 through Tk. For simplicity, assume that each study has contributed only one effect size 
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for one outcome variable. Depending on available study data, the Ti may be regression slopes 
(bi), correlations (ri or some form of partial correlation), standardized mean differences (di), or 
odds ratios.  We also assume that all studies contribute the same kind of effect sizes. If quite 
different types of effects (e.g., d’s and r’s) have been extracted, they must be expressed on the 
same metric to be analyzed together.  
 Assume further that each Ti estimates some population parameter θi, and that in large 
samples the effect size is approximately normal, such that Ti ~ N(θi, σ2(θi)). Most meta-analytic 
effect sizes follow this form (Hedges & Olkin, 1985; Keef & Roberts, 2004). Typically σ2(θi) is 
a function of the sample size ni and, for some Ti, of the parameter θi. We will denote the sample 
estimate of σ2(θi) as Vi. Also, we let p represent the full number of features to be considered in a 
particular analysis, and define xib as a variable representing study feature b from the ith study. 
 Given this asymptotic distributional form, many meta-analytic approaches use inverse 
variance weighting (e.g., via weighted least squares (WLS) or generalized least squares (GLS) 
analyses; Hedges & Olkin, 1985). Further, in meta-analyses of QEs it is critical to account for 
the coded design differences and study features discussed above, as well as for any remaining 
unexplained differences between studies. The model we propose is thus 
 
 =  +  +  +⋯+ 

 +  +  	,                       (1) 
where ei ~ N(0, Vi) represents sampling error in Ti and ui ~ N(0, τ) represents variation not 
explained by the model. Under model 1, the weights wi = 1/[Vi + ̂] are used, and WLS, GLS and 
Bayes estimation methods may be applied. The xij reflect study features that may relate to 
between studies differences in effect sizes.  If the ui term is omitted, model 1 is a fixed-effects 
model and provides tests of model fit. Omnibus tests of model significance are available under 
fixed-effects and random-effects models for single or multiple study outcomes. For those who 
choose to avoid significance testing, all of these methods provide standard errors and confidence 
intervals. Model 1 is not the only model in contention for use in analyses. Stanley and 
Doucouliagos (2015, 2016) argue that an unrestricted fixed-effects WLS analysis provides 
estimates that are statistically comparable to random-effects estimates in all cases and superior to 
random-effects in many.  Other estimation approaches have also been developed, including 
maximum likelihood as well as Bayesian approaches (e.g., Thompson & Sharp, 1999). 
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 With no predictors, model (1) provides the random-effects estimate of the overall mean.  
However, it would be rare to stop at a simple random-effects mean, and in some cases that 
average may be meaningless, especially if effect-size parameters  are not consistently defined 
across studies (e.g., when different factors are controlled across studies). 
 The x’s in the model represent methodological differences (e.g., presence/absence of a 
given covariate or confound) or other features such as intensity or duration of treatment, and the 
like.  A variety of design characteristics and substantively important treatment or sample features 
should be analyzed. However, when the number of estimates (studies) is limited and many study 
features are to be examined, it may not be possible to consider all predictors in one analysis. We 
suggest prioritizing the most critical predictors and including all of them initially (barring 
significant issues of multicollinearity). We would give top priority to x’s representing biases, 
controls, and design variations. Differences in the nature of the interventions or populations can 
capture excess heterogeneity when added as further moderator variables. The final estimated 
model can be used to obtain the conditional effect size of each design by substituting specific 
combinations of moderator variable values into the formula in model 1, or used to predict to an 
optimal result, as suggested by Rubin (1992). In cases of small meta-analyses, key predictors 
could be run in several sets so as to have fewer predictors per model. Also α levels could be 
reduced to control for multiple analyses being run, though this would make it harder for slope 
tests to reach significance. 
5.1  Categorical predictors  
 For categorical moderators, a series of dummy variable x’s can be modeled. However, 
ANOVA-like models (for p groups) are often easier to use (e.g., Hedges, 1982). Due to space 
considerations we do not elaborate on the ANOVA-like model here. A related approach 
considers categories of studies as panels. Rockers et al. (2015, p. 517, citing Donald & Lang, 
2007) identify the fixed-effects panel model as a general QE design for primary research that 
encompasses both difference-in-difference and control before-and-after QE designs.  Stanley and 
Doucouliagos (2012) have argued that using fixed-effects panel meta-regression models gives 
the systematic reviewer the opportunity to elevate inherently observational meta-analyses to the 
status of a QE by controlling variations in study quality and other study-level biases or 
confounders.  
5.2  Publication bias 
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 The regression model above has been generalized to accommodate publication bias, by 
incorporating a predictor with values equal to the standard error or variance of the effect size Ti. 
Moreno et al. (2009) provide a thorough study of such models including Egger’s original method 
(Egger et al., 1997) in which the standard error or variance is the only predictor. Different 
weighting schemes have been applied as well. Multiple regressions with substantive or design-
based predictors in addition to the standard error or variance appear to investigate potential 
publication bias conditional on other possible sources of heterogeneity (Stanley & Doucouliagos, 
2012, 2014). Simulation studies (e.g., Koetse et al., 2010) have shown that meta-regression 
analysis can simultaneously correct multiple sources of bias in the primary literature, including 
potential publication selection bias (e.g., Stanley & Doucouliagos, 2016).    
 
6  CONCLUSION 
 Quasi-experimental studies are likely to contain greater heterogeneity across studies than 
is typical among RCTs. However, meta-analytic methods are up to this challenge when the 
relevant research literature contains sufficient information to identify and control statistically the 
many potential sources of bias and heterogeneity.  Finally, the meta-analyst who undertakes the 
approaches suggested in this article should exercise extreme caution not to make causal 
statements regarding the relationship between the effect sizes and modeled study features.  
Relationships between moderators and study outcomes (i.e., the effect size) are observational 
even when the primary studies in question are randomized (see Thompson & Higgins, 2002).      
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